Versuchen GOLD - Frei
Indo-US trade deal is not just about trade
Business Standard
|February 13, 2026
The deal shifts the US posture towards India from hostile to neutral, and that matters for growth
The India-United States (US) trade deal, for which a framework for an interim agreement has been agreed, will not lack critics. The Congress party has called it a surrender. A farmers’ organisation has called for protests. Many will pore over the fine print once the details are finalised and argue that the deal is more favourable to the US.
We need to be clear about a couple of things. First, any nation negotiating a trade deal with the Trump administration must expect the deal to be tipped in favour of the US. President Donald Trump has made it clear that his priority is to reset America’s economic equations with the rest of the world. He is determined to use the economic and military might of the US to do so.
For the entire post-War period until recently, the US was happy to let the advantage lie with many of its trade partners. It believed that it was economically strong enough to do so. Sharing prosperity with partners, the US believed, would make for world peace and it would also keep the world safe from communism.
Not anymore. Mr Trump rode to power in 2016 by insisting that the time had come to reorder trade relationships to the benefit of the US. He didn’t quite manage to do so, partly because his initiatives were scuttled by Washington establishment status-quoists in his Cabinet. In his second term, Mr Trump is determined not to make that mistake. He has filled his administration with loyalists who will faithfully execute his orders.
Last July, Mr Trump reiterated his perception of where matters stand. He said in a post, “The United States of America has been ripped off on TRADE (and MILITARY!) by friend and foe alike, for DECADES. It has come at a cost of TRILLIONS OF DOLLARS, and it is just not sustainable any longer — And never was!” In any trade deal, therefore, it will be Advantage US.
Diese Geschichte stammt aus der February 13, 2026-Ausgabe von Business Standard.
Abonnieren Sie Magzter GOLD, um auf Tausende kuratierter Premium-Geschichten und über 9.000 Zeitschriften und Zeitungen zuzugreifen.
Sie sind bereits Abonnent? Anmelden
WEITERE GESCHICHTEN VON Business Standard
Business Standard
FD left without a Will? Here's how children, grandchildren can claim money
Fixed deposits (FDs) are a common savings tool across Indian households.
1 min
February 14, 2026
Business Standard
Reliance gets US licence to directly buy Venezuela oil
Private-sector oil refiner Reliance Industries Limited (RIL) last week received a general licence from the United States (US) government to buy Venezuelan oil, an industry executive told Business Standard.
1 mins
February 14, 2026
Business Standard
Torrent Pharma profit rises 26%
Ahmedabad-based Torrent Pharmaceuticals on Friday posted a 26 per cent year-on-year (Y-0-Y) increase in net profit on a consolidated basis for the third quarter of the financial year (Q3FY26) to %635 crore. The revenue from operations also grew 17.6 per cent to %3,303 crore.
1 min
February 14, 2026
Business Standard
Delhi-Dhaka ties may warm up after BNP’s win
But stronger Jamaat a concern
2 mins
February 14, 2026
Business Standard
Friday the 13th caps a week of AI-sparked horror in IT stocks
Top software exporters suffer nearly ₹5 trn mcap loss as rout deepens
2 mins
February 14, 2026
Business Standard
BEE may rationalise technology credits
The Bureau of Energy Efficiency (BEE) is planning to rationalise the list of technologies that carmakers can classify as \"fuel-saving\" to claim \"technology derogation credits\" while calculating the average emission of carbon dioxide in a fleet of vehicles, Business Standard has learnt.
2 mins
February 14, 2026
Business Standard
Leverage, time & the long game
This is the game every nation is now learning to play. Some are finding new allies or seeing value among nations where they'd seen marginal interest. The starkest example is India and Europe
5 mins
February 14, 2026
Business Standard
‘Biopharma Shakti shows India focusing on being biopharma hub’
Fresh from a reduction in debt and a capital raise of $1 billion, Biocon Ltd is sharpening its focus on biosimilars, GLP-1s (glucagon-like peptide-1s), and manufacturing on a global scale. In a video interaction with Sohini Das, Biocon Group Chairperson Kiran Mazumdar-Shaw explains how lower borrowing costs will lift profitability, and why regulatory reform and adopting artificial intelligence (AI) are critical for India to be a biopharma hub. Edited excerpts:
3 mins
February 14, 2026
Business Standard
Munich Conference: German Chancellor calls for reset with US as old global order crumbles
German Chancellor Friedrich Merz on Friday called for a stronger Europe to reset its ties with the United States, wanting Washington to “repair and revive trust” in a dangerous new era of great power politics as the old global order crumbles.
1 mins
February 14, 2026
Business Standard
₹70 lakh for 10 secs: India-Pak clash sends ad rates over the ropes
Days after Pakistan backtracked on its earlier decision to boycott the marquee showdown with India at the ongoing ICC Men's T20 World Cup, the commercial upswing following that clarity is already visible.
2 mins
February 14, 2026
Listen
Translate
Change font size
